Please provide the Chinese content you would like translated into American English.Shanghai Zhongxinjian Co., Ltd. (CPGJ)The Antibody Engineering Research Center (abbreviated as Antibody Center), led by our company, is currently the only antibody engineering research institution within the country. The center focuses on addressing the significant demands for antibody technology in the treatment of malignant tumors, infectious diseases, and systemic diseases, aiming to break through technical bottlenecks in antibody development. It researches and develops recombinant antibodies with independent intellectual property rights, and carries out major key common technologies such as large-scale continuous perfusion and fed-batch culture of antibody drugs, large-scale purification of effector antibody proteins, and formulation of antibody macromolecules.
As an important tool for antibody research,Shanghai CPGJ Pharmaceutical Co., Ltd. has introduced the new Chirascan Plus circular dichroism (CD) spectrometer, which was put into operation in March 2014. The model is produced by the UK-based company Application of Light Physics and is primarily used for the study of protein secondary and tertiary structures, thermal stability, and antibody screening.
The newly introduced round-doubling CD spectrometer has been installed.China Telecom Health Biotechnology Research InstituteThe China Everbright Health Biotechnology Research Institute is a fully-owned R&D institution of Shanghai China Everbright Health Pharmaceutical Co., Ltd., committed to the application research and process development of new drugs for the company, aiming to meet unmet medical needs. The Institute has established an exchange mechanism with multiple research institutions in Europe and America, actively participating in the cutting-edge international biotechnology. It has developed a novel drug with a dual-functional humanized monoclonal antibody clone at the international forefront, thereby advancing alongside foreign peers in the development of the third-generation biotechnology.